You are here: Industry Insights > BioNTech

News List

Pfizer and BioNTech sign deal with Japan for 120 mn doses of mRNA-based COVID-19 vaccine expresspharma
August 03, 2020
The companies have begun a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October 2020.
Pfizer-BioNTech to commence late stage study of COVID-19 vaccine candidate expresspharma
July 29, 2020
BioNTech and Pfizer informed they would begin the Phase2/3 trial to evaluate their COVID-19 vaccine candidate.
Pfizer and BioNTech select lead mRNA vaccine against COVID-19 pharmatimes
July 28, 2020
Pfizer and BioNTech have started a global Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA (modRNA) candidate from their BNT162 mRNA-based vaccine programme against SARS-CoV-2.
US sets global benchmark for COVID-19 vaccine price at around the cost of a flu shot expresspharma
July 27, 2020
Unlike other vaccine deals signed by the government, Pfizer and BioNTech will not collect a payment until their vaccine proves to be safe and effective in a large pivotal clinical trial expected to start this month.
US to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine expresspharma
July 24, 2020
The contract for 100 million doses of the vaccine amounts to a $39 price tag for what is likely to be a two-dose course of treatment.
U.S. Inks $2B COVID-19 Vax Deal with Pfizer, BioNTech contractpharma
July 24, 2020
U.S. government placed an initial order of 100 million doses and can acquire up to 500 million additional doses.
US inks $1.95bn deal for Pfizer and BioNTech’s Covid-19 vaccine pharmaceutical-technology
July 23, 2020
The US Department of Health and Human Services (HHS) and the Department of Defense have executed an agreement valued at $1.95bn with Pfizer and BioNTech for up to 600 million doses of the companies’ Covid-19 vaccine candidate, BNT162.
Brazil approves human trials for third COVID-19 vaccine in collaboration with Pfizer, BioNTech expresspharma
July 23, 2020
The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful.
UK Government secures early access to 90 million doses of COVID-19 vaccines europeanpharmaceuticalreview
July 21, 2020
The government has entered partnerships with Pfizer and Valneva to secure doses of several promising COVID-19 vaccines and secured COVID-19 neutralising antibody treatments from AstraZeneca.
China gives the go-ahead for human trials of BioNTech’s COVID vaccine candidate expresspharma
July 20, 2020
China has approved an early-stage trial in humans of German firm BioNTech’s experimental COVID-19 vaccine, its local partner Shanghai Fosun Pharmaceutical said.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page